Hundreds of current and former staffers at the National Institutes of Health (NIH) are urging agency director Jay ...

Axsome Therapeutics has hit a costly snag in its mission to bring esreboxetine to market for fibromyalgia. | Axsome ...

Get an insider’s look at the Bio International Convention in Boston before it even begins! Whether you’ll be attending in person, following along remotely, or simply want to ensure you’re up ...

Reflow Medical has secured a groundbreaking green light from the FDA for its retrievable stent system, designed to boost blood flow through blockages in the lower limbs while leaving noth | The ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

Along with its Caris Assure liquid biopsy test for treatment selection and its MI Profile tumor tissue sequencing platform, ...

Elevation Oncology, which spent the spring fending off activist investor demands to wind down, has become the latest ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. | NewAmsterdam ...

Researchers unaffiliated with an academic library can find accessing scientific papers pricy. But some have found a way to ...

Global trade uncertainty and evolving tariff policies are shifting how bioscience companies view their supply chains.   | ...